Compass Pathways announced that the US FDA has accepted its Investigational New Drug application for COMP360, a psilocybin-based therapy for PTSD.
#CMPS #Psilocybin #PTSD #CMPSStock #CMPSNews #CompassPathways #CompassPathwaysStock #CompassPathwaysNews #ClinicalTrial #COMP360 #FDAApproval
$CMPS